Explore
Validate
LearnBAF393
antibody from Novus Biologicals
Targeting: PPBP
b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BAF393 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal CXCL7/NAP-2 Antibody
- Antibody type
- Polyclonal
Submitted references Development of a Glycosaminoglycan Derived, Selectin Targeting Anti-Adhesive Coating to Treat Endothelial Cell Dysfunction.
Up-regulation of platelet activation in hemophilia A.
High platelet reactivity is associated with myocardial infarction in premenopausal women: a population-based case-control study.
Wodicka JR, Chambers AM, Sangha GS, Goergen CJ, Panitch A
Pharmaceuticals (Basel, Switzerland) 2017 Mar 29;10(2)
Pharmaceuticals (Basel, Switzerland) 2017 Mar 29;10(2)
Up-regulation of platelet activation in hemophilia A.
van Bladel ER, Roest M, de Groot PG, Schutgens RE
Haematologica 2011 Jun;96(6):888-95
Haematologica 2011 Jun;96(6):888-95
High platelet reactivity is associated with myocardial infarction in premenopausal women: a population-based case-control study.
Snoep JD, Roest M, Barendrecht AD, De Groot PG, Rosendaal FR, Van Der Bom JG
Journal of thrombosis and haemostasis : JTH 2010 May;8(5):906-13
Journal of thrombosis and haemostasis : JTH 2010 May;8(5):906-13
No comments: Submit comment
No validations: Submit validation data